A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis

Journal of Molecular Medicine

Volumn 83, Issue 6, 2005, Pages 478-485

  Hamann, Lutz ^a   Gomma, Abuzeid ^b   Schröder, Nicolas W J ^a   Stamme, Cordula ^c   Glaeser, Christiane ^d   Schulz, Susanne ^d   Gross, Michael ^a   Anker, Stefan D ^a,b   Fox, Kim ^b   Schumann, Ralf R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LÜBECK   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Gene polymorphism; Genetics; Innate immunity; Restenosis

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; IMPLANTATION; INFLAMMATION; INNATE IMMUNITY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MICROBIAL ACTIVITY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN FUNCTION; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

CORONARY RESTENOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTRAITS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; RISK FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 21544462582     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0643-7     Document Type: Article

References (44)

1. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316:1371-1375
2. Rajagopal V, Rockson SG (2003) Coronary restenosis: a review of mechanisms and management. Am J Med 115:547-553
3. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
4. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1287-1397
5. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q (2000) Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102:833-839
6. Horne BD, Muhlestein JB, Strobel GG, Carlquist JF, Bair TL, Anderson JL (2002) Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 144:491-500
7. Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22:361-403
8. Miller YI, Chang MK, Binder CJ, Shaw PX, Witztum JL (2003) Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol 14:437-445
9. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216
10. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376
11. Pasterkamp G, Van Keulen JK, De Kleijn DP (2004) Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Investig 34:328-334
12. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192
13. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, de Prost D (2003) Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23:e61-e64
14. Yang IA, Holloway JW, Ye S (2003) TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis 170:187-190
15. Sasu S, LaVerda D, Qureshi N, Golenbock DT, Beasley D (2001) Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 89:244-250
16. Rothfuchs AG, Trumstedt C, Wigzell H, Rottenberg ME (2004) Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4 - myeloid differentiation factor 88 - IFN-alpha beta - STAT1 signaling. J Immunol 172:6345-6353
17. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77:4588-4596
18. Prebeck S, Kirschning C, Durr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T (2001) Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167:3316-3323
19. Kirschning CJ, Schumann RR (2002) TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 270:121-144
20. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ (2002) Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105:1158-1161
21. Fonarow GC, Horwich TB (2003) Prevention of heart failure: effective strategies to combat the growing epidemic. Rev Cardiovasc Med 4:8-17
22. Scheuner MT (2001) Genetic predisposition to coronary artery disease. Curr Opin Cardiol 16:251-260
23. 2+/calmodulin-dependent protein kinase II identified by transgene integration in an embryonic lethal mouse mutant. Mol Cell Biol 12:3644-3652
24. Marenberg ME, Risch N, Berkman LF, Floderus B, Faire U de (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041-1046
25. Wang X, Paigen B (2002) Comparative genetics of atherosclerosis and restenosis: exploration with mouse models. Arterioscler Thromb Vasc Biol 22:884-886
26. Schröder NW, Hermann C, Hamann L, Göbel UB, Hartung T, Schumann RR (2003) High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 81:368-372
27. Hamann L, Hamprecht A, Gomma AH, Schumann RR (2004) Rapid and inexpensive real time PCR for genotyping functional polymorphisms within the toll-like receptor-2, -4, and -9 genes. J Immunol Methods 285:281-291
28. Gomma AH, Elrayess MA, Knight CJ, Hawe E, Fox KM, Humphries SE (2002) The endothelial nitric oxide synthase (Glu298Asp and -786T→C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J 23:1955-1962
29. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101:10679-10684
30. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10:416-421
31. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229-241
32. Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-263
33. Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, Krieken JH van, Hartung T, Adema G, Kullberg BJ (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172:3712-3718
34. Frothingham C (1911) The relationship between acute infectious diseases and arterial lesions. Arch Intern Med 8:153-162
35. Fabricant CG, Fabricant J, Litrenta MM, Minick CR (1978) Virus-induced atherosclerosis. J Exp Med 148:335-340
36. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP (1995) Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 92:6911-6914
37. Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H, Brunec M, Franz N, Konturek JW, Pieniazek P, Hahn EG, Konturek SJ, Thale J, Warnecke H (2002) Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34:398-402
38. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, Lu Y, Papapanou PN, Schmidt AM (2003) Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 23:1405-1411
39. Gibson FC III, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA (2004) Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109:2801-2806
40. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME (1983) Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2:644-647
41. Witherell HL, Smith KL, Friedman GD, Ley C, Thom DH, Orentreich N, Vogelman JH, Parsonnet J (2003) C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction. Ann Epidemiol 13:170-177
42. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B (1997) Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study, ROXIS study group. Lancet 350:404-407
43. Hollestelle SC, De Vries MR, Van Keulen JK, Schoneveld AH, Vink A, Strijder CF, Van Middelaar BJ, Pasterkamp G, Quax PH, De Kleijn DP (2004) Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109:393-398
44. Hashimoto M, Asai Y, Ogawa T (2004) Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. Int Immunol 16:1431-1437